Palisade Bio (PALI) Operating Income Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,386.07% |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | -365.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -365.28% |
| Dec 31, 2025 | -195.12% |
| Sep 30, 2025 | 18.68% |
| Jun 30, 2025 | 32.49% |
| Mar 31, 2025 | 37.11% |
| Dec 31, 2024 | -7.23% |
| Sep 30, 2024 | 4.90% |
| Jun 30, 2024 | -16.68% |
| Mar 31, 2024 | -45.24% |
| Dec 31, 2023 | 18.04% |
| Sep 30, 2023 | 14.39% |
| Jun 30, 2023 | -1.04% |
| Mar 31, 2023 | 34.95% |
| Dec 31, 2022 | 4.44% |
| Sep 30, 2022 | -46.32% |
| Jun 30, 2022 | 89.13% |
| Mar 31, 2022 | -98.98% |
| Dec 31, 2021 | -24.10% |
| Sep 30, 2021 | -66.08% |
| Jun 30, 2021 | -1,684.79% |
| Mar 31, 2021 | 1.83% |
| Dec 31, 2020 | -52.16% |
| Sep 30, 2020 | 14.51% |
| Jun 30, 2020 | 4.03% |
| Mar 31, 2020 | 18.97% |
| Dec 31, 2019 | -18.16% |
| Sep 30, 2019 | -1.99% |
| Jun 30, 2019 | 5.17% |
| Mar 31, 2019 | -4.58% |
| Dec 31, 2018 | 20.46% |
| Sep 30, 2018 | 19.52% |
| Jun 30, 2018 | 52.04% |
| Mar 31, 2018 | 44.49% |
| Dec 31, 2017 | 59.85% |
| Sep 30, 2017 | 47.37% |
| Jun 30, 2017 | -10.01% |
| Mar 31, 2017 | 32.11% |
| Dec 31, 2016 | -29.89% |
| Sep 30, 2016 | 5.40% |
| Jun 30, 2016 | 23.23% |
| Mar 31, 2016 | -35.13% |
| Dec 31, 2015 | 6.24% |
| Sep 30, 2015 | -26.56% |
| Jun 30, 2015 | -42.25% |
| Mar 31, 2015 | 10.89% |
| Dec 31, 2014 | -67.99% |
| Sep 30, 2014 | -13.01% |
| Jun 30, 2014 | -8.52% |
| Mar 31, 2014 | -79.02% |
| Dec 31, 2013 | -1.31% |
| Sep 30, 2013 | -40.68% |
| Jun 30, 2013 | -35.76% |
| Mar 31, 2013 | -17.40% |
| Dec 31, 2012 | -6.43% |
| Sep 30, 2012 | 19.85% |
| Jun 30, 2012 | 35.04% |
| Mar 31, 2012 | 30.35% |
| Dec 31, 2011 | 25.72% |
| Sep 30, 2011 | 17.86% |
| Jun 30, 2011 | 12.54% |